semaglutide and lymphedema Frontiers Does GLP-1 Help with Lymphoedema?

The drug does not just interact with other diabetes medications

It was approved by the US Food and Drugs Administration (FDA) in 2014 and is currently one of the most commonly prescribed treatments for treating type II diabetes

On top of that, the SURPASS-3 MRI sub study showed that a substantial fraction of the lean mass lost on tirzepatide was intramuscular fat, not muscle tissue

We dont have a definitive answer yet, but heres what we do know: Using GLP-1s for at least 12 months improves outcomes Stopping often leads to weight regain

The results are categorized into three main sections: diabetes and overweight, hypertension, dyslipidemia, and atherosclerosis, each accompanied by a brief discussion and conclusion